tiprankstipranks
Plus Therapeutics Advances Radiotherapeutics in Q3 2024
PremiumCompany AnnouncementsPlus Therapeutics Advances Radiotherapeutics in Q3 2024
2M ago
Plus Therapeutics reports Q3 EPS (37c), consensus (56c)
Premium
The Fly
Plus Therapeutics reports Q3 EPS (37c), consensus (56c)
2M ago
Plus Therapeutics, SpectronRx announce manufacturing partnership
Premium
The Fly
Plus Therapeutics, SpectronRx announce manufacturing partnership
2M ago
Plus Therapeutics presents data at 2024 CNS Annual Meeting
PremiumThe FlyPlus Therapeutics presents data at 2024 CNS Annual Meeting
4M ago
Plus Therapeutics reports Q2 EPS (71c), consensus (53c)
Premium
The Fly
Plus Therapeutics reports Q2 EPS (71c), consensus (53c)
5M ago
Plus Therapeutics presents FORESEE trial results
Premium
The Fly
Plus Therapeutics presents FORESEE trial results
5M ago
Plus Therapeutics appoints Fuller as VP, reports $3.3M advance payment
PremiumThe FlyPlus Therapeutics appoints Fuller as VP, reports $3.3M advance payment
7M ago
Y-mAbs Therapeutics appoints LaFrance as Chief Development Officer
Premium
The Fly
Y-mAbs Therapeutics appoints LaFrance as Chief Development Officer
7M ago
Plus Therapeutics Secures Loan to Terminate Debt and Regain Freedom
Premium
Company Announcements
Plus Therapeutics Secures Loan to Terminate Debt and Regain Freedom
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100